NY-AQARA
23.11.2021 09:02:36 CET | Business Wire | Press release
Aqara, a leading provider of smart home products, announced today the launch of its next-gen flagship home security camera, the Camera Hub G3. The new camera is a 2K, pan-and-tilt camera with the local facial and gesture recognition features, and it integrates a built-in Zigbee 3.0 hub, allowing the device to connect up to 128 Aqara accessories*. It is now available on the Aqara Amazon brand stores in the US , Canada and France , and is also expected to be sold by authorized Aqara retailers in North America, Europe and Asia in the following weeks**.
Thanks to a powerful NPU-equipped processor, the Aqara Camera Hub G3 supports facial recognition and gesture recognition features, both of which can be used to trigger home automations. Users can configure to receive push notifications when their young kids arrive home or when a stranger is detected (i.e. a familiar face was not detected), or to stop video recording when the face of a family member or a preset hand gesture is recognized. The AI-enabled features will make homes safer, and make people’s lives even easier as users can now trigger home automation with certain hand gestures or simply a recognized face.
The G3 camera hub also supports automatic cruising, face tracking as well as pet tracking, all enabled by the 110° wide-angle lens and the pan-and-tilt motor which provides up to 340° rotation angle. The pan-and-tilt motor can be controlled manually, by the preset cruising path, or via home automations (for example, to turn to the front door when Door & Window Sensor is triggered). Combined with the high-resolution 2304×1296 pixel sensor and the infrared night vision enabled by the 940 nm LEDs, which are invisible at night, the G3 protects homes in 360-degree with no blind spot, day and night.
Compared to the previous G2H Camera Hub, the new G3 provides other advanced features including:
- Wider compatibility with third-party platforms : as a camera it supports not only HomeKit Secure Video*** but also streaming to Amazon Alexa and Google Assistant smart displays, while as a hub it allows connected child devices to support a wide range of third-party ecosystems and voice assistants, such as HomeKit, Alexa, Google Home, IFTTT, and more;
- Local infrared control : the built-in IR controller allows the G3 to automate the infrared-compatible devices, and the IR automation is local which means it remains functioning without the Internet connection;
- Dual-band Wi-Fi support : both 2.4GHz and 5GHz Wi-Fi networks are supported;
- Privacy protection : it is equipped with a privacy shutter that physically covers the camera lens, and the shutter can be activated manually and automatically;
- Type-C port with video out : it uses the modern and universal connector that supports low-latency, high-definition video output via UVC protocol.
To celebrate the launch, Aqara is now offering limited-time discounts for the new Camera Hub G3 on its Amazon brand stores. North American customers will enjoy a 20% discount at check with the promo code USG3PRGE in the US and Canada , and the code will be valid through Nov 24, 2021. Aqara also offers French customers a 20€ OFF discount at its Amazon.fr store , with the promo code CAMERAG3FR, and the offering will expire on Nov 25, 2021.
For more details of the G3 camera hub, please visit our website .
* To connect up to 128 devices, Zigbee routers/repeaters such as Smart Wall Switch (With Neutral) and Smart Plug are required.
** Product availability may vary among different retail channels, and could be updated all the time. It’s recommended to check with the regional retailer(s) for real time availability.
*** In HomeKit Secure Video mode, the camera records in Full HD 1080p and Pan/Tilt controls are not available due to the current limitations of HomeKit technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211123005627/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 10:00:00 CET | Press release
The two partners launch “Bianca”, the first large-scale digitalisation initiative in Italy focused on histopathological samples, aimed at training AI algorithms to support pathologists’ diagnostic activities. The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 10:00:00 CET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 10:00:00 CET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 10:00:00 CET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 09:15:00 CET | Press release
This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment OptionsOveporexton is an Orexin Agonist Designed to Restore Orexin Signaling and Address the Underlying Orexin Deficiency that Causes Narcolepsy Type 1The Prescription Drug User Fee Act (PDUFA) Target Action Date is the Third Quarter of this Calendar Year Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
